Perceptive Advisors LLC insider trades
Open-market stock purchases and sales by Perceptive Advisors LLC, Unknown at Immatics NV, from SEC Form 4 filings since Feb 24, 2011.
Track record: 49% of 117 scored buys are up 5% or more since purchase, averaging +27%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | IMTX Immatics NV | Bought (not open market) | — |
| Jun 11, 2026 | MGTX MeiraGTx Holdings plc | Bought (not open market) | — |
| Jun 10, 2026 | SLDB Solid Biosciences Inc | Bought (not open market) | — |
| Apr 17, 2026 | MGTX MeiraGTx Holdings plc | Bought (not open market) | $5M |
| Mar 25, 2026 | MGTX MeiraGTx Holdings plc | Sold (not open market) | $6M |
| Mar 25, 2026 | MGTX MeiraGTx Holdings plc | Bought (not open market) | $3.2M |
| Mar 25, 2026 | MGTX MeiraGTx Holdings plc | Bought (not open market) | $2.4M |
| Mar 25, 2026 | MGTX MeiraGTx Holdings plc | Sold (not open market) | $6M |
| Mar 9, 2026 | SLDB Solid Biosciences Inc | Bought (not open market) | $50M |
| Dec 31, 2025 | MGTX MeiraGTx Holdings plc | Sold (not open market) | $18.2M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $6.3M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $2.1M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $8.7M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $24.4M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $22.5M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $2.9M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $8.1M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $7.5M |
| Dec 23, 2025 | ATHA Athira Pharma, Inc | Bought (not open market) | $5.5K |
| Nov 13, 2025 | LYRA Lyra Therapeutics, Inc | Sold | $112K |
| Nov 13, 2025 | LYRA Lyra Therapeutics, Inc | Sold | $12.5K |
| Nov 12, 2025 | LYRA Lyra Therapeutics, Inc | Sold | $31.9K |
| Nov 12, 2025 | LYRA Lyra Therapeutics, Inc | Sold | $3.6K |
| Nov 11, 2025 | LYRA Lyra Therapeutics, Inc | Sold | $20.6K |
| Nov 11, 2025 | LYRA Lyra Therapeutics, Inc | Sold | $2.3K |
Companies traded
- IMTX Immatics NV: other filings, last Jun 16, 2026
- MGTX MeiraGTx Holdings plc: 6 buys, last Jun 11, 2026
- SLDB Solid Biosciences Inc: 6 buys, last Jun 10, 2026
- ATHA Athira Pharma, Inc: 7 buys, last Dec 23, 2025
- LYRA Lyra Therapeutics, Inc: 4 buys, 12 sales, last Nov 13, 2025
- ADGM Adagio Medical Holdings, Inc: 2 buys, last Oct 20, 2025
- OBIO Orchestra BioMed Holdings, Inc: 2 buys, last Aug 1, 2025
- ACRV Acrivon Therapeutics, Inc: 1 buy, 5 sales, last May 1, 2025
- ALDX Aldeyra Therapeutics, Inc: 31 buys, 3 sales, last Apr 3, 2025
- NAUT Nautilus Biotechnology, Inc: 3 buys, last Jun 14, 2024
- CERE Cerevel Therapeutics Holdings, Inc: 9 buys, last Feb 20, 2024
- LIAN LianBio: 9 buys, last Feb 15, 2024
Get free alerts when Perceptive Advisors LLC files a new trade →